India BSE NSE Trading Suspension Orders — May 04, 2026

Board meeting on May 20, 2026, to approve FY26 audited results and recommend final dividend, signaling potential shareholder returns via capital allocation

Earlier board meeting on May 13, 2026, at 2:30 p.m. for Q4/FY audited results and dividend, providing quicker visibility vs. Apollo's May 20 date

Trading window closure extended to May 22, 2026 (48 hours post-results), compliant with SEBI PIT Regulations, reflecting disciplined insider practices

Trading window closed April 1 to May 15, 2026, shorter duration than Apollo's, potentially indicating less complex disclosures

Final dividend recommendation for FY25-26 under consideration, consistent capital allocation trend amid neutral sentiment

Higher materiality score (8/10 vs. Apollo 6/10), highlighting stronger market anticipation for housing finance sector results

Compliance with SEBI Listing Regs 29, 42, 50 and prior intimation on March 24, 2026, demonstrates proactive governance

Non-publication of unaudited Q4/FY results avoids pre-emptive volatility, preserving upside surprise potential

No insider transactions or pledges reported during open window prior to April 1 closure, absence of sells signals management conviction

Scrip codes BSE 508869/NSE APOLLOHOSP with ISIN INE437A01024 confirmed, facilitating easy tracking for pre-earnings positioning

CIN L65922MH1989PLC052277 and website www.lichousing.com provide transparent access to further updates

Identical trading window start (April 1, 2026) shows synchronized sector preparation, no outlier delays [NEUTRAL but BULLISH on stability]

Audited results pending May 20, 2026, with no prior unaudited data or period comparisons, heightens surprise risk

Final dividend 'if any' introduces payout uncertainty, potential for zero recommendation impacting yields

Trading closure to May 22, 2026 (longer than LIC's May 15), may signal more material/complex FY26 disclosures

Explicit non-publication of unaudited Q4/FY results could lead to larger post-earnings gaps vs. peers with prelim data

Closed windows from April 1 prevent visibility into management conviction, no buys/sells to gauge sentiment

Lower 6/10 materiality vs. LIC's 8/10 suggests relatively muted market focus, potential underreaction to surprises

No suspensions/delistings but pre-earnings announcements in volatile stream, watch for halt triggers on adverse results

May 13 meeting precedes Apollo by 1 week, first-mover risk if results disappoint NBFC sector peers

Absence of YoY/QoQ trends, ratios, or operational data in filings limits pre-emptive trend analysis

Strict SEBI adherence could amplify penalties if any disclosure delays occur post-board meetings

Position ahead of May 20 board for potential FY26 final dividend approval, capital allocation focus in healthcare

May 13 results offer alpha from housing finance sector first-look, higher 8/10 materiality for outsized moves

Monitor insider activity post-May 15/22 windows for buys signaling conviction after results

SEBI Regs compliance and prior March 24 intimation position as stable play vs. suspension-risk peers

Audited results sans unaudited priors could reveal margin outperformance if costs controlled

May 13-20 board meetings create paired trade opportunity (long LIC short Apollo or vice versa on relative results)

Neutral tone masks potential positive guidance changes in FY26 outlooks during meetings

Longer window implies higher materiality surprise upside if results beat, trading at potential discount pre-May 20

Real-time updates via www.lichousing.com enable rapid reaction to board outcomes

Absence of halts/delistings in these filings highlights relative safety for event-driven strategies

Both healthcare and housing finance firms locked windows from April 1, 2026 (Apollo to May 22, LIC to May 15), standard protocol signaling no early insider conviction patterns but cluster risk for volatility

Identical 'final dividend if any' for FY25-26 across filings indicates shareholder return priority in NBFC/healthcare, potential yield enhancement vs. reinvestment

May 13 (LIC) and May 20 (Apollo) create sequential disclosures, amplifying sector interlinks (e.g., NBFC funding healthcare capex)

100% neutral across 2 filings with materiality skew (avg 7/10), reflects procedural nature but hides FY26 trend reveals

Zero transactions/pledges noted pre-closure, contrasting potential sells in suspension-prone peers; implies stable management holdings

Full SEBI adherence (Regs 29/42/50, PIT) in both, reducing delisting risks vs. non-compliant small-caps in stream

May 13, 2026, 2:30 p.m. - monitor audited Q4/FY26 results, dividend decision, and initial guidance for NBFC trends

May 20, 2026 - track standalone/consolidated FY26 results, final dividend, and any forward-looking hospital capacity updates

Reopens May 15, 2026 - watch for post-results insider buys/sells or pledges signaling conviction

Reopens May 22, 2026 - monitor director/promoter activity after extended closure for healthcare sector conviction

Post-board announcements - flag record dates under SEBI Reg 42 for yield capture opportunities

Post-May 13 results - compare QoQ/YoY metrics vs. peers for margin/volume outperformance

Reference March 24, 2026 letter - watch if FY26 results deviate from hinted trends

Post-May 22 for both - monitor NSE/BSE for trading halts if results trigger >20% moves in volatile environment